Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Learn more about Lorella’s recap of 2021 at GenomSys and her outlook for 2022 for herself and the company through the following quick questions:

Happy New Year and good morning Lorella. What was your most outstanding achievement at GenomSys in 2021?

I think the most outstanding achievement for GenomSys is that from starting as a start-up, in 2021, it has become a real company with a good and solid group of employees, where each one is highly specialized in their own field. My significant personal achievement was quickly learning the ropes of the genomic industry and better understanding how to collaborate with my coworkers. In my opinion, we have come a long way, building a great team that is genuinely able to make personalized medicine a reality.

What was the most important thing you learned in 2021?

The most important thing that I learned was how to work and collaborate while being at distance due to the COVID situation and as we are located at two different offices, one in Lugano and one in Lausanne. At first, it seemed easy only to use emails, phone calls, or videoconferences, but indeed for many tasks, especially for a young start-up with lots of new members over last year, the personal interaction in the offices was missing. But what can I say? We also managed to beat the circumstances and achieve so much: The launch of GenomSys Variant Analyzer and GenomSys MPEG-G Codec Suite, as well as the successful company certification.

What are your expectations for you and/or GenomSys for 2022?

Regarding GenomSys, I look forward to seeing the new version of GenomSys Variant Analyzer launched, which promises to have many powerful and useful features. Regarding my personal expectations: I want to learn and improve my knowledge as usual, because I’m very curious and I want to be at my best in my field.

If you have any further questions for Lorella or about GenomSys, please feel free to contact us.

Picture: chrisreadingfoto / pixabay

Schedule a call

[contact-form-7 id="224" title="contact call"]